As Medicare’s GLP-1 Bridge Program Launches, ISMP Offers Guidance for Pharmacists

Originally published by our sister publication Specialty Pharmacy ContinuumBy Fran KritzMedicare’s new Bridge program, which launched on July 1,makes available certain glucagon-like peptide-1 receptor agonist (GLP-1) drugs for a $50 copay, which is hundreds less than the current cash prices for patients not covered for the drugs by insurance.figure { display:inline-block; margin:0.5em; border:thin silver solid; padding:0.5em; font-size:smaller; text-indent:0; }figure img { max-width:100%;